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Neurochemicals have a large impact on brain states and animal behavior but are
notoriously hard to detect accurately in the living brain. Recently developed genetically
encoded sensors obtained from engineering a circularly permuted green fluorescent
protein into G-protein coupled receptors (GPCR) provided a vital boost to neuroscience,
by innovating the way we monitor neural communication. These new probes are
becoming widely successful due to their flexible combination with state of the art
optogenetic tools and in vivo imaging techniques, mainly fiber photometry and 2-photon
microscopy, to dissect dynamic changes in brain chemicals with unprecedented spatial
and temporal resolution. Here, we highlight current approaches and challenges as well
as novel insights in the process of GPCR sensor development, and discuss possible
future directions of the field.
Keywords: neurotransmitters, neuromodulators, GPCRs, fluorescent proteins, genetically encoded sensors,
in vivo imaging
INTRODUCTION
A variety of neurochemicals, including transmitters, modulators, peptides and hormones, are
constantly released within the brain during neuronal and glial communication, and play a
fundamental role in coordinating physiological brain functions. Tools for monitoring the dynamic
changes of individual neurochemicals are therefore highly desirable. For decades fast-scan cyclic
voltammetry and microdialysis have been the gold-standard techniques used for measuring the
extracellular concentrations of neurochemicals during animal behavior (Kehr and Yoshitake, 2013).
However, intrinsic challenges of these analytical chemistry techniques, such the limited molecular
specificity and number of detectable neurochemicals for voltammetry (Carter and Shieh, 2010), and
poor temporal resolution for microdialysis (Chefer et al., 2009), as well as the low spatial resolution
in both systems generated a great need for new technologies capable of bridging these gaps. Specific
advantages and limitations of these techniques for monitoring individual neurotransmitters in
brain tissue are reviewed in Zeng et al. (2019).
Optical microscopy techniques in combination with genetically encoded sensors are emerging
as a powerful solution that can elegantly answer this need. In particular the recently introduced
genetically encoded sensors based on a single circularly permuted green fluorescent protein
(cpGFP) engineered into G-protein coupled receptors (GPCR), which for simplicity here we refer
to as “GPCR sensors,” can enable the detection of neuromodulatory molecules at high resolution in
awake behaving animals (Patriarchi et al., 2018; Sun et al., 2018). One of the greatest benefits of these
new genetically encoded sensors is their unique ability to detect spatially resolved neuromodulatory
signals at high-resolution, which was demonstrated using two-photon imaging in the fly brain (Sun
et al., 2018; Handler et al., 2019) and in the mouse cortex (Patriarchi et al., 2018). Exciting new
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questions in the field can now be addressed thanks to
the level of spatial and temporal resolution allowed by
these tools, such as whether neuromodulatory signals can be
transmitted in a cell-type specific manner or heterogeneously
from neuronal projections.
These tools purposely combine the high ligand-binding
affinity and molecular specificity which were fine-tuned in the
receptor by natural evolution, with the large sensitivity typical
of intensity-based probes engineered from cpGFP (Marvin et al.,
2011; Chen et al., 2013b; Marvin et al., 2013; Kostyuk et al.,
2019). Because GPCRs are a very large family of receptors
(class-A alone comprises approximately 350 members without
including odorant receptors (Pándy-Szekeres et al., 2018), for
an overview see Figures 1A,B), in principle they represent a
largely unexplored pool from which novel fluorescent sensors
could be developed to probe a vast amount of endogenous
neurochemicals. Although FRET or BRET-based biosensors of
GPCR activation have been available for a long time (Vilardaga
et al., 2003; Sleno et al., 2016), to date only a few GPCR
sensors have been introduced for in vivo sensing of dopamine
(Patriarchi et al., 2018; Sun et al., 2018), acetylcholine (Jing
et al., 2018, 2019a), and norepinephrine (Feng et al., 2019).
The ability to reveal the intimate spatial and temporal details
of neurotransmitter release in living animals is only possible
with this new type of sensors and not with previously available
FRET or BRET-based probes, due to their limited dynamic range
(Jing et al., 2019b). Thus, the innovative field of GPCR sensor
development represents a true technological breakthrough and,
while still in its early days, is likely to continue expanding to cover





The first examples of GPCR sensors were only recently
introduced when two similar but independent engineering
approaches were published almost simultaneously (Patriarchi
et al., 2018; Sun et al., 2018). These studies produced the
two alternative genetically encoded dopamine sensor families
named dLight1 and GRAB-DA1. The general concept behind
both approaches is similar: inserting cpGFP at specific locations
between the transmembrane helix 5 (TM5) and 6 (TM6) of a
human dopamine receptor is used as a mean to generate sensitive
fluorescent reporters of receptor conformational change. Due
to their genetically encoded nature these sensors can be easily
expressed in living animals, and because conformational motion
at the interface of TM5 and TM6 is a classical feature of
GPCR activation and reflects ligand binding (Venkatakrishnan
et al., 2013), their fluorescent signals can be used as a proxy of
endogenous dopamine dynamics.
When compared side by side the approaches taken to develop
the two classes of sensors have important differences. In dLight1
cpGFP completely replaces the third intracellular loop (ICL3) as
well as small portions of TM5 and TM6 of the D1 dopamine
receptor (DRD1) (Patriarchi et al., 2018), while in GRAB-DA1
it is inserted within the ICL3 of the D2 dopamine receptor
(DRD2), and a large stretch of 30 aminoacids is carried over
from the original ICL3 (Figure 1C; Sun et al., 2018). Similar to
GRAB-DA1 sensors, the approaches taken for developing both
the acetylcholine and norepinephrine sensors also relied on the
presence of a variable amount of ICL3 residues surrounding
cpGFP (Jing et al., 2018; Feng et al., 2019).
In all cases, the final goal is to maximize the coupling between
receptor conformational change and the fluorescence response of
cpGFP. This process, builds on previous knowledge established
for genetically encoded sensors of similar design (Chen et al.,
2013b; Marvin et al., 2013) and mostly involves the generation
of libraries where the linker regions connecting GPCR to cpGFP
are subject to sequence randomization and the resulting sensor
variants are individually screened for their fluorescence response.
Strikingly, the sensor design used in the development of
dLight1, which is completely devoid of ICL3 residues, was
demonstrated to be quite versatile. In fact, the simple grafting of a
“fluorescent protein module” (i.e., cpGFP flanked by short linkers
derived from the dopamine sensor) into other GPCR subtypes
made it possible to rapidly generate preliminary sensors for
norepinephrine, serotonin, melatonin, and opioid neuropeptides
(Patriarchi et al., 2018). Although these prototype probes may
not sensitive enough for in vivo application, they may represent
an ideal starting point for further optimization through targeted
mutagenesis at a reduced number of sites, and thus could provide
a useful shortcut in a process that is otherwise very costly and
time-consuming. Considering that the ICL3 is an extremely
variable region among different class-A GPCRs (Figure 1B)
both in terms of size and composition (Otaki and Firestein,
2001; Unal and Karnik, 2012), and that this region is predicted
to be intrinsically disordered, based on sequence composition
(Jaakola et al., 2005), the presence of a considerable portion
of the ICL3 in GRAB-DA1 is likely to prevent the versatile
grafting of the fluorescent protein module for rapid engineering
of novel GPCR sensors.
The concept of versatile engineering is somewhat reflected in
the field of GPCR crystallography, where long and disordered
ICL3 sequences are counterproductive and are thus commonly
replaced with small fusion proteins (e.g., T4 lysozyme; Thorsen
et al., 2014), or stabilized with the aid of nanobodies (Manglik
et al., 2017). We believe that, in order to be most effective, future
engineering efforts should follow a “semi-rational” approach
where the starting point for cpGFP insertion into the TM5-TM6
interface of a GPCR is set by the receptor sequence (e.g., the
positively charged residues identified during the development of
dLight1; Patriarchi et al., 2018) and site-directed mutagenesis
screening follows. In this regard, a deeper understanding of
the relationship between the receptor, linker, and fluorescent
protein components of the sensor, which could be obtained
by structural studies. For instance a sensor structure obtained
by cryogenic electron microscopy would provide important
information on the specific orientation of charged, polar and
hydrophobic residue sidechains at the GPCR/cpGFP interface,
which could guide future sensor optimization efforts. The current
lack of structural information for both dLight1 and GRAB-DA1
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FIGURE 1 | A snapshot of the current GPCR sensor engineering landscape. (A) Class-A GPCR family tree. Receptors are grouped and branches are color-coded
based on ligand type. Gray-scale circles in front of the receptor name represent the number of currently available ligands (white: 0, light gray: >100, gray: >500 and
black: >1000). Reproduced from Pándy-Szekeres et al. (2018). (B) Length distribution of ICL3 (region where cpGFP is inserted during the sensor engineering
process) for several class-A GPCRs highlights the high degree of variability in this region among different receptors. The number of ICL3 aminoacid residues is
shown on the x axis, while the relative probability of each length from a total of 89 analyzed GPCRs is shown on the y axis. Reproduced with permission from Otaki
and Firestein (2001). (C) Schematic depiction of representative members of the two classes of genetically encoded dopamine sensor classes developed to date:
dLight1.1 and GRAB-DA1m. Aminoacid residues of sensor sequence belonging to the original dopamine receptors (DRD1 and DRD2) are shown in the snake-plot.
The insertion position of circularly permuted green fluorescent protein (cpGFP) is indicated for both sensor types. N-term, N-terminus; ICL, intracellular loop; ECL,
extracellular loop; C-term, C-terminus. Third intracellular loop, ICL3, is highlighted in yellow.
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sensors, makes it very difficult to achieve a clear understanding of
how the receptor conformational change is capable of triggering
the fluorescence of cpGFP, and to elucidate the role that linker
regions and the residual ICL3 residues play in this process.
Overall, every screening approach in GPCR sensor
development faces the same obstacle: a large number of
variants to be screened and the low throughput of current
mammalian cell-based screening assays. To overcome this hurdle
possible strategies could make use of a recently established
screening assay, combining Fluorescence-Activated Cell Sorting
(FACS) with robotic cell-picking, which was successfully used
to evolve voltage sensors derived from integral membrane
proteins (Piatkevich et al., 2018). However, implementation
of a robotic arm for cell-picking may not be easily applicable
in many labs due to the inherent technical complexity of the
system. As an alternative, we envision that in the future it may
become advantageous to devise novel FACS-based screening
methods, perhaps in combination with microfluidic channels
that can cyclically integrate two independent cell-sorting steps.
Such innovative assay concepts could in theory enable selection
of sensor variants based on fluorescence in both an active and
inactive state from a library pool of 106–109 cells, which would
ideally suit GPCR sensor development and dramatically increase
the scale of the process.
Although all attention of current GPCR sensor screening
approaches focuses on obtaining sensors with the largest maximal
fluorescence changes, this property is not by itself sufficient to
guarantee success when testing the probe in the living brain.
The apparent affinity of the probe is another important factor
to be considered when imaging neuromodulators. Owing to
its design each probe can only reliably work within a narrow
concentration range. Because the levels of release for endogenous
neuromodulators are variable among different brain regions,
mostly depending on the abundance of neuromodulatory
projections in the area, multiple probes with complementary
affinity ranges need to be developed in order to most sensitively
detect the same neuromodulator in different regions. Up to now,
sensors with different affinity ranges have been obtained mostly
by using different receptor subtypes as a starting point (in the
case of dopamine sensors, DRD1, DRD2, DRD4) (Patriarchi et al.,
2018; Sun et al., 2018), and in few cases have been tuned by
mutagenesis of one specific site in the GPCR moiety (Patriarchi
et al., 2018; Feng et al., 2019). Future sensor development
could tremendously benefit from computational modeling-based
approaches aimed at fine tuning the sensor apparent affinity or
even ligand-selectivity (Feng et al., 2017).
THE OPPORTUNITY OF A LIFETIME
A deeper understanding of the basic photophysical properties
of GPCR sensors may lead to novel applications based on
different fluorescence properties (e.g., fluorescence lifetime)
and open new research directions. In fact, while intensity-based
fluorescence readouts can provide valuable information about
the dynamics of biological systems using simple instrumentation,
they suffer from limitations (e.g., wavelength-dependent
absorption and scattering, different detector sensitivities or
expression dependence for single-wavelength sensors) that
make them unsuitable for quantitative measurements of analyte
concentrations (Waters, 2009; Yellen and Mongeon, 2015).
These drawbacks are particularly critical for deep brain imaging
or when comparing different samples or measurements done
with different instrumentation. In the case of GPCR sensors, the
kinetics of a biological response to stimulation can be reliably
accessed (Patriarchi et al., 2018; Sun et al., 2018), but important
parameters such as the absolute extent of the response or the
baseline levels of the analyte are much more difficult to retrieve.
On the contrary, fluorescence lifetime is an intensive rather
than extensive physical quantity, which reflects the kinetics of
excited to ground state relaxation and is independent on the
absolute intensity of the signal (Lakowicz, 2006). This latter
factor is critical as it eliminates the effects of laser fluctuations,
tissue absorption and detector sensitivity. Also, in a microscopy
or fiber photometry setup, the lifetime is much less affected
by tissue scattering than intensity (Dowling et al., 1997;
Vishwanath et al., 2002).
All these advantages have sparked a growing interest in
techniques like fluorescence lifetime imaging (FLIM) (Berezin
and Achilefu, 2010; Borst and Visser, 2010; Chen et al., 2013a)
or fluorescence lifetime fiber photometry (FLiP) (Brown et al.,
1994; Saxl et al., 2011; Lagarto et al., 2019; Lee et al., 2019a,b),
which have been successfully applied to obtain more quantitative
information on analyte concentrations (Díaz-García et al., 2017;
Melo et al., 2017) or protein interactions (Yasuda et al., 2006; Sun
et al., 2011; Walther et al., 2011). Recent studies investigated the
optimization and application of fluorescent protein (FP) pairs to
produce FLIM sensors based on fluorescence resonance energy
transfer (FLIM-FRET) (Visser et al., 2010; George Abraham et al.,
2015; Martin et al., 2018). The process of FRET introduces
an additional path for the excited state decay of a “donor”
fluorophore, due to the transfer of excitation energy to an
“acceptor.” Due to the relationship between quantum yield
and lifetime of a fluorophore (Lakowicz, 2006; Noomnarm and
Clegg, 2009), the effect of FRET on lifetime is particularly
straightforward (the higher the FRET efficiency, the shorter the
donor lifetime) and the design of FLIM-FRET sensors is, at least
in first approximation, conceptually simple.
On the other hand, the field of FLIM sensors based on
circularly permuted fluorescent proteins (cpFPs) is still largely
underdeveloped. While some groups have reported the use
of cpFP sensors with FLIM readout (Tantama et al., 2011;
Mongeon et al., 2016; Melo et al., 2017; Díaz-García et al.,
2019), the sensor characterization has been mostly limited to
empirical calibrations, and no clear guidelines for the choice
of FPs that would give optimal lifetime changes currently exist.
In our opinion, this is largely due to the complexity of the
problem. While in FRET sensors a single photophysical process
is responsible for the observed changes, in cpFPs a complex
combination of effects needs to be taken into account (Barnett
et al., 2017; Molina et al., 2019). In a cpFP sensor, the acid
and basic forms of the chromophore exist in equilibrium.
Each form has its own absorption spectrum and fluorescence
quantum yield (usually, only the basic form has a high quantum
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yield and is defined as “emissive” form), and the equilibrium
concentrations can change upon opening and closing of the
protein barrel (Figure 2A). Interconversion between the two
forms can happen also in the excited state (Meech, 2009; Barnett
et al., 2017), so that the excitation of the acid form can result
in the emission of the basic one. In the case of multiphoton
absorption, also the absorption cross-sections can depend on the
barrel conformation (Molina et al., 2019). As a consequence of
this complexity, the relation between intensity and lifetime is very
difficult to predict.
Ignoring for simplicity excited-state dynamics and
multiphoton effects, the photophysical basis of sensor function
can be described by two limit cases (Figure 2B). In the first
one, the changes in the fluorescence intensity of the sensor
are due exclusively to changes in the relative abundance
of the acid-base equilibrium forms of the chromophore
upon analyte binding, while the quantum yield of the basic
form (the emissive one) remains unaffected (Figure 2A).
In this scenario, while fluorescence intensity changes can
be large (and wavelength dependent), no change in lifetime
is expected. In the second limit case, there are no changes
in the acid-base equilibrium upon analyte binding, but
the fluorescence quantum yield of the basic form changes.
While this is not always the case, very often variations in
fluorescence quantum yield are accompanied by variations
in lifetime (Lakowicz, 2006). Real world scenarios lie in
between these two extremes, and thus FLIM sensors with
smaller or larger (and more or less wavelength-dependent)
lifetime changes can in principle be developed based on
these considerations.
Careful photophysical studies (Barnett et al., 2017; Molina
et al., 2019) have shown that even for seemingly similar cpFP
sensors the mechanisms that determine the fluorescence response
can change considerably, and that good candidates for FLIM
definitely exist. We expect that in the future more studies will
be devoted to this specific aspect and cpFPs optimized for
FLIM readouts will start to emerge. This will in turn boost
the field of GPCR-based sensors, paving the way toward a
more quantitative understanding of the role of neurochemicals
in brain functions. Particularly for physiological dynamics that
do not manifest themselves in fast and quasi-binary transients
(as is often the case for calcium signals), quantification of
molar concentrations of the target molecule is essential. This
will allow for reliable comparisons among different brain areas,
different animals or data acquired by different labs, and for
analyzing data obtained in chronic long-term imaging over
days and months.
THE PUSH TOWARD RED-SHIFTED
WAVELENGTHS
It is reasonable to imagine that in the near future the development
of GPCR sensors will also expand toward both red and near-
infrared (NIR) wavelengths, by taking advantage of a large variety
of fluorescent proteins available at these wavelengths (Rodriguez
et al., 2017). This has for instance been the case for genetically
encoded calcium sensors, which have recently been developed at
near-infrared wavelengths based on mIFP (Qian et al., 2019) or
GAF-FP (Subach et al., 2019). Such GPCR sensors would benefit
from inherent advantages of using red-shifted light for excitation,
such as increased penetration depth and lower phototoxicity.
They would also increase the quality and quantity of potential
applications. For instance, the availability of red-shifted GPCR
sensors would enable “mix and match” approaches where green
and red sensors for two different neurotransmitters could be
combined in dual-color fluorescence imaging, similar to what
has been previously achieved for red calcium sensors (Dana
et al., 2016). This approach could be used for instance to resolve
long-standing challenges, such as the unequivocal proof of co-
release between two neurotransmitters. A prominent example
of this is the case of dopamine and norepinephrine: previous
studies imply that the two catecholamines can be synthesized
and simultaneously released by the locus coeruleus (Kempadoo
et al., 2016; Takeuchi et al., 2016), however, direct evidence for
this is lacking as well as the important information of whether
this phenomenon is constitutive or regulated.
The landscape of raw materials for building GPCR sensors
is constantly evolving, as new fluorescent and chromoproteins
are added to the plate (Lambert et al., 2019). Development
of GPCR sensors based on near-infrared fluorescent proteins
could in principle expand the solution space for multiplex
imaging, and allow us to image up to three different aspects
of neural communication and activity simultaneously. In
addition, the NIR window (650–900 nm) offers improved optical
transmission properties in living animals because of the relatively
lower absorption component of endogenous molecules such
as hemoglobin or melanin (Ntziachristos et al., 2003). We
predict that the development of GPCR sensors absorbing in
this wavelength range, that could for instance be engineered
based on bacterial phytochromes (e.g., BphP1; Yao et al.,
2016), will enable successful application of the probes with
optoacoustic imaging, a scalable imaging modality capable of
resolving whole-brain activity three-dimensionally at millisecond
time scale and 100 µm resolution non-invasively (i.e., without
the need for optical fiber or gradient index lense implantation)
(Gottschalk et al., 2019). Another advantage of red/NIR FPs
is that their photophysical properties are optimal for three-
photon absorption (3PA) in the 1700 nm optical window (Horton
et al., 2013; Deng et al., 2019), which is recently emerging as
a superior technique for deep in vivo imaging (Horton et al.,
2013; Miller et al., 2017). Due to the much reduced scattering and
absorption, 3PA at these wavelengths is limited only by signal-
to-noise ratio (which depends on protein brightness) up to more
than 3 mm depth (Horton et al., 2013), and structural imaging
of neurons has already been demonstrated at a depth of 1.4 mm
(Horton et al., 2013), reaching the subcortical region of the mouse
brain. Especially if combined with FLIM detection (Ni et al.,
2019), that eliminates artifacts due to absorption and scattering,
3PA at 1700 nm would constitute a promising strategy for
non-invasive imaging of neurochemicals in deep brain regions,
while at the same time improving the cell resolution ability in
densely labeled samples with respect to two-photon absorption
(Ouzounov et al., 2017).
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FIGURE 2 | Simplified photophysical description of cpFP sensors with emphasis on FLIM. (A) Schematic representation of the equilibrium occurring in GPCR
sensors (left) and of their spectroscopic properties (right). It can be observed how the absorption spectrum is actually the sum of two bands, one due to the
protonated (acid) form of the chromophore and one to the deprotonated (basic) one. The latter is also the only emissive form in most cpFPs used in sensors. This is
certainly true if the sensor is excited at longer wavelengths, as shown in these examples, where only the basic form absorbs. (B) Representative spectral changes for
the two limit cases described in the text (left), and FLIM images and histograms of RINm5f cells expressing the cpFP sensor TriPer before (right, top) and after (right,
bottom) exposure to 0.2 mM H2O2 (reproduced without modifications from Melo et al., 2017; under Creative Commons license:
http://creativecommons.org/licenses/by/4.0/). Possible candidates for FLIM can be identified by looking at the changes of the absorption and fluorescence spectra
of the sensors upon analyte binding. If only the acid/base equilibrium changes, but not the quantum yield of the basic form, then no lifetime change is expected (limit
case 1). An easy way to conceptualize this phenomenon is that if the absorbance of the open and closed forms at the excitation wavelength would be the same (i.e.,
if the two would absorb the same number of photons), then their fluorescence intensity would also be the same (column “absorbance match”). On the other hand, if
there are changes in the fluorescence intensity but not in the acid/base equilibrium (limit case 2), then changes in the quantum yield are occurring and will likely (but
not necessarily) result in a lifetime change. We note that this is a simplified scheme which takes into account only a subset of the photophysical processes occurring
in cpFP sensors, thus: (a) unexpected results may occur by strictly following this simplified scheme as a general rule for all sensors, (b) lifetime changes can occur
also as result of other mechanisms.
DISCUSSION
Considering the important and multifaceted roles that
neurochemicals play in the nervous system, the thirst for
novel sensor types capable of probing these molecules in their
natural environment is likely to continue increasing. Although
GPCR sensors are an elegant technological solution, some
caveats need to be considered. One example is the potential
interference with endogenous neuromodulatory signaling of
target cells, which has not yet been extensively characterized in
living animals. Our hope is that, with time, a careful evaluation
of the side-effects of GPCR sensor expression will elucidate best
experimental practices that can allow us to make the most out
of these tools without significantly altering the system under
investigation. For a more in-depth discussion of the limitations
of these tools please refer to our previously published protocols
(Patriarchi et al., 2019). All things considered, we envision a
bright future for GPCR sensor development, with important
achievements to be expected along at least three directions.
First, the continuous improvement of existing GPCR sensors
(in terms of increased dynamic range, basal brightness, kinetics,
photostability, etc.) will follow an analogous path to that of the
GCaMP family of calcium sensors (Dana et al., 2019), and will
build upon the continuous discovery and directed evolution
of novel and improved variants of fluorescent proteins and
chromoproteins. Second, in striking difference with calcium
sensors, the optical measurement of the actual concentrations
of neurochemicals in vivo, rather than merely their dynamic
behavior, is a much needed task. The demonstration that GPCR
sensors can be utilized in quantitative techniques such as FLIM
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and the design of specifically optimized sensors is still lacking
and will likely be a central topic in the field in the near
future. Third, the need for multiplexed imaging will not only
spur the design of novel GPCR sensors to probe an increasing
number of neurochemicals, but also the diversification of
existing sensors in terms of emission wavelengths. The latter
will dramatically expand the possibilities to simultaneously
image multiple neurochemicals, or observe how their dynamics
correlate with other important phenomena such as calcium
or metabolite transients. While the path ahead for this new
class of sensors certainly presents its challenges, some of which
were highlighted in this work, their unique features and wide
applicability will keep us and others motivated to develop new
and improved variations which will clearly contribute to shape a
bright and colorful future for neurochemical imaging.
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